Daniel Do
Impact in
- Cell Biology top 10%
- Zebrafish Biomedical Research Applications
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Zebrafish Biomedical Research Applications 4
- Oncology 3
- Vascular Tumors and Angiosarcomas 1
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Qiqi Yang (2 shared papers)David M. Langenau (2 shared papers)Chuan Yan (2 shared papers)Guillermo Pablo Sangster (2 shared papers)Maureen G. Heldmann (1 shared paper)Benjamin C. Li (1 shared paper)Carlos Previgliano (1 shared paper)John Franklin Rawls (1 shared paper)
- Journals
- PLoS ONE (2 papers)Molecular Immunology (1 paper)Blood (1 paper)Current Developments in Nutrition (1 paper)American Journal of Therapeutics (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Daniel Do
15 papers receiving 427 citations
Peers
Comparison fields: 5 of 52
- Cell Biology 140
- Oncology 77
- Pulmonary and Respiratory Medicine 64
- Genetics 16
- Immunology 33
Countries citing papers authored by Daniel Do
This map shows the geographic impact of Daniel Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Do more than expected).
Fields of papers citing papers by Daniel Do
This network shows the impact of papers produced by Daniel Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Do. The network helps show where Daniel Do may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Do, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 212 | |
| 2 | 2022 | 42 | |
| 3 | 2022 | 36 | |
| 4 | 2010 | 32 | |
| 5 | 2019 | 23 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 17 | |
| 9 | 2018 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 6 | |
| 12 | Littoral cell angioma: review of the literature and case report. | 2014 | 2 |
| 13 | 2024 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 1 |
About Daniel Do
Daniel Do is a scholar working on Cell Biology, Oncology, Microbiology, Surgery and Pharmacology, having authored 15 papers that have together received 430 indexed citations. Recurring topics across this work include Zebrafish Biomedical Research Applications (4 papers), Acute Lymphoblastic Leukemia research (2 papers), Antimicrobial Peptides and Activities (1 paper), Adrenal and Paraganglionic Tumors (1 paper), Protein Tyrosine Phosphatases (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cell Biology (140 citations), Oncology (77 citations), Pulmonary and Respiratory Medicine (64 citations), Genetics (16 citations) and Immunology (33 citations). Daniel Do has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Qiqi Yang, David M. Langenau, Chuan Yan, Guillermo Pablo Sangster, Maureen G. Heldmann, Benjamin C. Li, Carlos Previgliano, John Franklin Rawls, Manisha Bahl and Sarah Mercaldo. Their work appears in journals such as PLoS ONE, Molecular Immunology, Blood, Current Developments in Nutrition and American Journal of Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.